Klaria Pharma Holding AB (publ.) reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was SEK 0.619 million. Revenue was SEK 0.536 million compared to SEK 0.017 million a year ago. Net loss was SEK 10.81 million compared to SEK 16.11 million a year ago. Basic loss per share from continuing operations was SEK 0.1 compared to SEK 0.27 a year ago.
For the nine months, sales was SEK 7.15 million compared to SEK 3.66 million a year ago. Revenue was SEK 7.4 million compared to SEK 4.09 million a year ago. Net loss was SEK 26.31 million compared to SEK 50.88 million a year ago. Basic loss per share from continuing operations was SEK 0.27 compared to SEK 0.88 a year ago.